TSLA Directional Report
Analysis based on market close April 2, 2026
Outlook
Bearish with a weak gravitational pull toward $380 max pain, but dominated by negative GEX and massive net put flow. Confidence: 6/10. The regime has shifted decisively from a fragile pin to a trending, negative-gamma environment.
Conflicts: Max pain ladder still rises to $380-$400, creating a weak upward magnet.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-49.7M
DEX: +114.7M shares
Gamma flip: N/A
NTM gamma: No specific gamma flip, but -$49.7M GEX means dealer hedging will accelerate any spot move. A rally would force dealers to sell shares to re-hedge, adding selling pressure.
IV Analysis
IV vs VIX: N/A (VIX not provided), but IV 55.0% is extremely elevated historically for TSLA โ selling premium is attractive on vol alone.
Term structure: Humped with near-term kink: 4/6 (31.2%) < 4/8 (37.8%) < 4/10 (40.2%). Peak ~49% in late 2026. The 4/8-4/10 hump may price a near-term event.
Skew: The 6.6 vol-point differential between 4/6 (31.2%) and 4/10 (40.2%) supports a calendar spread (sell 4/10, buy 4/6) for volatility convergence.
Flow Analysis
Net premium: -$432.1M bearish; P/C vol 0.71, P/C OI 0.72 (call-heavy positioning but put premium dominates).
Directional prints: $380P: -$49.9M net premium, $370P: -$46.3M net premium โ large, likely protective put buying. $355C: +$22.6M net premium โ could be bullish bets or short covering. Volume vs OI on $650C 4/10 is 107.9x at 112.5% IV โ either speculative lottery ticket buying or closing of existing shorts.
Unusual: $650C 4/10: Vol 101,412 vs OI 940 (107.9x) at IV 112.5% โ extreme speculation or complex spread leg.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Iron condor | Weak | GEX negative AND IV >55% โ trending regime with high tail risk. Avoid. | Simultaneous wing breach from accelerated moves. |
| Cash-secured put / put spread | Moderate-Weak | Sell $340/$335 put spread 4/17 (15 DTE). Collect premium below 1w EM low. | Negative GEX accelerates downside through strikes. |
| Covered call | Moderate | Own stock, sell $380C 4/17 against. Targets max pain, collects high premium. | Stock called away if pin pushes above $380; spot decline hurts. |
| Long puts / bear put spread | Moderate-Strong | Buy $355P / sell $345P 4/17. Bets on downside toward 2w EM low. | IV crush if spot stabilizes; pin holds. |
| Long calls | Weak | High IV (55%) makes long calls expensive; negative GEX limits upside momentum. Avoid. | IV crush and theta decay. |
| Calendar/diagonal spread | Moderate | Reverse calendar: Sell $360C 4/10 (IV 40.2%), Buy $360C 4/6 (IV 31.2%). Bets on vol convergence. | Spot moves far from $360, losing calendar alignment. |
| PMCC / LEAPS diagonal | Moderate | Buy Jan 2027 $300 LEAPS (IV ~49%), sell 4/17 $380C against. Leverages high term structure, targets range. | Capital intensive; spot decline hurts LEAPS. |
| Short stock | Moderate-Strong | Direct expression of negative GEX and bearish flow. Entry near $365. | Squeeze toward $380 max pain. |
| Naked put sale (CSP) | Moderate-Weak | Sell $340P 4/17. High premium, defined-risk entry for stock. Place well below spot. | Assignment below $340 if trend accelerates. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for TSLA for 2026-04-02. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.